Advisors Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.1M | Sell |
127,450
-27,803
| -18% | -$3.66M | 0.25% | 77 |
|
|
2026
Q1 | $21.6M | Sell |
155,253
-7,370
| -5% | -$1.03M | 0.36% | 44 |
|
|
2025
Q4 | $20M | Sell |
162,623
-7,634
| -4% | -$928K | 0.34% | 46 |
|
|
2025
Q3 | $18.9M | Sell |
170,257
-35,774
| -17% | -$4.07M | 0.32% | 47 |
|
|
2025
Q2 | $22.8M | Sell |
206,031
-33,903
| -14% | -$3.61M | 0.41% | 32 |
|
|
2025
Q1 | $26.9M | Buy |
239,934
+14,358
| +6% | +$1.48M | 0.51% | 25 |
|
|
2024
Q4 | $20.8M | Sell |
225,576
-29,260
| -11% | -$2.63M | 0.38% | 38 |
|
|
2024
Q3 | $21.4M | Sell |
254,836
-18,896
| -7% | -$1.44M | 0.39% | 42 |
|
|
2024
Q2 | $18.8M | Buy |
273,732
+11,232
| +4% | +$750K | 0.37% | 45 |
|
|
2024
Q1 | $19.2M | Sell |
262,500
-11,718
| -4% | -$901K | 0.37% | 44 |
|
|
2023
Q4 | $22.2M | Sell |
274,218
-42,521
| -13% | -$3.31M | 0.45% | 36 |
|
|
2023
Q3 | $23.7M | Sell |
316,739
-3,397
| -1% | -$261K | 0.51% | 30 |
|
|
2023
Q2 | $24.7M | Sell |
320,136
-27,918
| -8% | -$2.23M | 0.5% | 35 |
|
|
2023
Q1 | $28.9M | Buy |
348,054
+45
| +0% | +$3.73K | 0.59% | 24 |
|
|
2022
Q4 | $29.9M | Buy |
348,009
+25,863
| +8% | +$2.05M | 0.62% | 24 |
|
|
2022
Q3 | $19.9M | Buy |
322,146
+18,525
| +6% | +$1.17M | 0.42% | 43 |
|
|
2022
Q2 | $18.8M | Buy |
303,621
+34,453
| +13% | +$2.13M | 0.36% | 52 |
|
|
2022
Q1 | $16M | Buy |
269,168
+19,875
| +8% | +$1.27M | 0.25% | 77 |
|
|
2021
Q4 | $18.1M | Buy |
249,293
+20,186
| +9% | +$1.39M | 0.26% | 69 |
|
|
2021
Q3 | $16M | Buy |
229,107
+14,808
| +7% | +$1.04M | 0.24% | 75 |
|
|
2021
Q2 | $14.8M | Buy |
214,299
+28,290
| +15% | +$1.89M | 0.22% | 80 |
|
|
2021
Q1 | $12M | Buy |
186,009
+4,393
| +2% | +$283K | 0.19% | 106 |
|
|
2020
Q4 | $10.6M | Sell |
181,616
-2,408
| -1% | -$145K | 0.18% | 110 |
|
|
2020
Q3 | $11.6M | Sell |
184,024
-18,903
| -9% | -$1.31M | 0.22% | 88 |
|
|
2020
Q2 | $15.6M | Sell |
202,927
-25,397
| -11% | -$1.95M | 0.3% | 60 |
|
|
2020
Q1 | $17.1M | Sell |
228,324
-25,411
| -10% | -$1.76M | 0.41% | 46 |
|
|
2019
Q4 | $16.5M | Buy |
253,735
+29,197
| +13% | +$1.9M | 0.29% | 76 |
|
|
2019
Q3 | $14.2M | Buy |
224,538
+27,824
| +14% | +$1.82M | 0.26% | 83 |
|
|
2019
Q2 | $13.3M | Buy |
196,714
+44,964
| +30% | +$2.96M | 0.24% | 90 |
|
|
2019
Q1 | $9.87M | Buy |
151,750
+60,575
| +66% | +$4.03M | 0.18% | 133 |
|
|
2018
Q4 | $5.7M | Buy |
91,175
+28,507
| +45% | +$1.99M | 0.11% | 210 |
|
|
2018
Q3 | $4.84M | Sell |
62,668
-57,510
| -48% | -$4.34M | 0.08% | 302 |
|
|
2018
Q2 | $8.51M | Sell |
120,178
-68,766
| -36% | -$4.86M | 0.14% | 170 |
|
|
2018
Q1 | $14.9M | Sell |
188,944
-3,546
| -2% | -$282K | 0.25% | 96 |
|
|
2017
Q4 | $13.8M | Buy |
192,490
+720
| +0.4% | +$54.7K | 0.23% | 109 |
|
|
2017
Q3 | $15.5M | Buy |
191,770
+29,118
| +18% | +$2.23M | 0.26% | 91 |
|
|
2017
Q2 | $11.5M | Buy |
162,652
+74,350
| +84% | +$4.95M | 0.19% | 128 |
|
|
2017
Q1 | $6M | Buy |
88,302
+30,933
| +54% | +$2.18M | 0.1% | 274 |
|
|
2016
Q4 | $4.11M | Sell |
57,369
-6,504
| -10% | -$483K | 0.07% | 393 |
|
|
2016
Q3 | $5.05M | Sell |
63,873
-6,647
| -9% | -$540K | 0.08% | 347 |
|
|
2016
Q2 | $5.88M | Buy |
70,520
+108
| +0.2% | +$9.59K | 0.1% | 312 |
|
|
2016
Q1 | $6.47M | Sell |
70,412
-1,667
| -2% | -$150K | 0.11% | 269 |
|
|
2015
Q4 | $7.29M | Buy |
72,079
+1,985
| +3% | +$207K | 0.12% | 249 |
|
|
2015
Q3 | $6.88M | Buy |
70,094
+1,581
| +2% | +$176K | 0.11% | 268 |
|
|
2015
Q2 | $8.02M | Buy |
68,513
+5,666
| +9% | +$619K | 0.11% | 252 |
|
|
2015
Q1 | $6.17M | Buy |
62,847
+1,781
| +3% | +$181K | 0.08% | 306 |
|
|
2014
Q4 | $5.76M | Buy |
61,066
+3,874
| +7% | +$401K | 0.08% | 311 |
|
|
2014
Q3 | $6.09M | Sell |
57,192
-1,701
| -3% | -$167K | 0.08% | 295 |
|
|
2014
Q2 | $4.88M | Buy |
58,893
+3,995
| +7% | +$311K | 0.07% | 344 |
|
|
2014
Q1 | $3.89M | Buy |
54,898
+6,346
| +13% | +$498K | 0.06% | 372 |
|
|
2013
Q4 | $3.65M | Buy |
48,552
+3,121
| +7% | +$217K | 0.06% | 382 |
|
|
2013
Q3 | $2.85M | Buy |
45,431
+4,082
| +10% | +$244K | 0.05% | 408 |
|
|
2013
Q2 | $2.12M | Buy |
+41,349
| New | +$2.16M | 0.04% | 449 |
|
Other funds holding GILD
Advisors Asset Management's GILD Position: Q2 2026 in Review
Advisors Asset Management reduced its Gilead Sciences (GILD) stake by 18% in Q2 2026, selling an estimated $3.66M and leaving 127,450 shares worth $16.1M. The position accounts for 0.25% of the portfolio, ranked #77.
Advisors Asset Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.9M in Q4 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Advisors Asset Management held 127,450 shares of Gilead Sciences worth $16.1M as of Q2 2026.
- Advisors Asset Management sold 27,803 Gilead Sciences shares in Q2 2026, an estimated $3.66M.
- Gilead Sciences made up 0.25% of Advisors Asset Management's portfolio in Q2 2026, its #77 holding.
- Advisors Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Advisors Asset Management's Gilead Sciences position peaked at $29.9M in Q4 2022.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.